Company Filing History:
Years Active: 2000-2001
Title: Rie Shinei: Innovator in Pharmaceutical Chemistry
Introduction
Rie Shinei is a prominent inventor based in Yokohama, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic applications. With a total of 2 patents, her work focuses on innovative solutions for progesterone-related diseases.
Latest Patents
Rie Shinei's latest patents include "Tetrahydronaphthofuranone derivatives and process for producing the same." This patent discloses compounds represented by a specific formula and their pharmaceutically acceptable salts. These compounds exhibit progesterone receptor binding inhibitory activity, making them valuable as therapeutic and prophylactic agents for various conditions. They are particularly useful as abortifacients, oral contraceptive pills, and carcinostatic agents for breast and ovarian cancer. Additionally, they serve as therapeutic agents for endometriosis, meningioma, myeloma, osteoporosis, and climacteric disturbances. Another notable patent is for "Tetrahydrobenzindolone derivatives," which further showcases her innovative approach to pharmaceutical development.
Career Highlights
Rie Shinei is associated with Meiji Seika Kaisha, Ltd., where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on women's health and cancer treatment.
Collaborations
Rie collaborates with esteemed colleagues, including Kenichi Kurihara and Yuji Tabata, who contribute to her research endeavors. Their combined expertise enhances the innovative capacity of their projects.
Conclusion
Rie Shinei stands out as a dedicated inventor in the pharmaceutical field, with her patents reflecting a commitment to addressing critical health issues. Her contributions are paving the way for advancements in therapeutic solutions.